{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:43:49Z","timestamp":1791164629302,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The immunodeficiency disorder Wiskott-Aldrich syndrome (WAS) leads to life-threatening hematopoietic cell dysfunction. We used WAS protein (WASp)\u2013deficient mice to analyze the in vivo efficacy of lentiviral (LV) vectors using either a viral-derived promoter, MND, or the human proximal WAS promoter (WS1.6) for human WASp expression. Transplantation of stem cells transduced with MND-huWASp LV resulted in sustained, endogenous levels of WASp in all hematopoietic lineages, progressive selection for WASp+ T, natural killer T and B cells, rescue of T-cell proliferation and cytokine production, and substantial restoration of marginal zone (MZ) B cells. In contrast, WS1.6-huWASp LV recipients exhibited subendogenous WASp expression in all cell types with only partial selection of WASp+ T cells and limited correction in MZ B-cell numbers. In parallel, WS1.6-huWASp LV recipients exhibited an altered B-cell compartment, including higher numbers of \u03bb-light-chain+ naive B cells, development of self-reactive CD11c+FAS+ B cells, and evidence for spontaneous germinal center (GC) responses. These observations correlated with B-cell hyperactivity and increased titers of immunoglobulin (Ig)G2c autoantibodies, suggesting that partial gene correction may predispose toward autoimmunity. Our findings identify the advantages and disadvantages associated with each vector and suggest further clinical development of the MND-huWASp LV for a future clinical trial for WAS.<\/jats:p>","DOI":"10.1182\/blood-2011-03-340711","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T05:21:23Z","timestamp":1332220883000},"page":"4395-4407","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome"],"prefix":"10.1182","volume":"119","author":[{"given":"Alexander","family":"Astrakhan","sequence":"first","affiliation":[{"name":"Departments of Immunology and"},{"name":"Pediatrics, University of Washington School of Medicine, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blythe D.","family":"Sather","sequence":"additional","affiliation":[{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Y.","family":"Ryu","sequence":"additional","affiliation":[{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socheath","family":"Khim","sequence":"additional","affiliation":[{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Humblet-Baron","sequence":"additional","affiliation":[{"name":"Center for Cellular and Molecular Therapy, Groupe Interdisciplinaire de G\u00e9noprot\u00e9mique Appliquee-Research, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Washington School of Medicine, Seattle, WA;"},{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol H.","family":"Miao","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Washington School of Medicine, Seattle, WA;"},{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Rawlings","sequence":"additional","affiliation":[{"name":"Departments of Immunology and"},{"name":"Pediatrics, University of Washington School of Medicine, Seattle, WA;"},{"name":"Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111809041671900_B1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.med.56.090203.104142","article-title":"Gene therapy for severe combined immunodeficiency.","volume":"56","author":"Cavazzana-Calvo","year":"2005","journal-title":"Ann Rev Med"},{"issue":"5","key":"2019111809041671900_B2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency.","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111809041671900_B3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for x-linked severe combined immunodeficiency.","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111809041671900_B4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOH.0b013e3282f30448","article-title":"Wiskott-aldrich syndrome.","volume":"15","author":"Notarangelo","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"20","key":"2019111809041671900_B5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the wiskott-aldrich syndrome.","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111809041671900_B6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/mt.2010.305","article-title":"Solving the problem of gamma-retroviral vectors containing long terminal repeats.","volume":"19","author":"Persons","year":"2011","journal-title":"Mol Ther"},{"issue":"6","key":"2019111809041671900_B7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for wiskott-aldrich syndrome in preclinical models.","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol Ther"},{"issue":"7","key":"2019111809041671900_B8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.gt.3302440","article-title":"A LV vector encoding the human wiskott-aldrich syndrome protein corrects immune and cytoskeletal defects in wasp knockout mice.","volume":"12","author":"Charrier","year":"2005","journal-title":"Gene Ther"},{"issue":"6","key":"2019111809041671900_B9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2002-05-1423","article-title":"Gene therapy for wiskott-aldrich syndrome: rescue of t-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111809041671900_B10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/hum.2007.098","article-title":"Hematopoietic-specific LV vectors circumvent cellular toxicity due to ectopic expression of wiskott-aldrich syndrome protein.","volume":"19","author":"Toscano","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"25","key":"2019111809041671900_B11","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","article-title":"Recent advances in understanding the pathophysiology of wiskott-aldrich syndrome.","volume":"113","author":"Bosticardo","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111809041671900_B12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in wiskott-aldrich syndrome: collaborative study of the european society for immunodeficiencies and european group for blood and marrow transplantation.","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111809041671900_B13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2011.02.027","article-title":"Gene therapy for primary immunodeficiencies: looking ahead, toward gene correction.","volume":"127","author":"Pessach","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2019111809041671900_B14","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20110200","article-title":"Wasp-deficient b cells play a critical, cell-intrinsic role in triggering autoimmunity.","volume":"208","author":"Becker-Herman","year":"2011","journal-title":"J Exp Med"},{"issue":"2","key":"2019111809041671900_B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI29539","article-title":"Wiskott-aldrich syndrome protein is required for regulatory T cell homeostasis.","volume":"117","author":"Humblet-Baron","year":"2007","journal-title":"J Clin Invest"},{"issue":"12","key":"2019111809041671900_B16","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.4049\/jimmunol.0804256","article-title":"Wiskott-aldrich syndrome protein is required for homeostasis and function of invariant nkt cells.","volume":"182","author":"Astrakhan","year":"2009","journal-title":"J Immunol"},{"issue":"10","key":"2019111809041671900_B17","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2008-02-140715","article-title":"Wasp confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.","volume":"112","author":"Westerberg","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111809041671900_B18","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood-2008-02-140814","article-title":"Wiskott-aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis.","volume":"112","author":"Meyer-Bahlburg","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111809041671900_B19","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.166.8.5245","article-title":"Spontaneous in vivo reversion of an inherited mutation in the wiskott-aldrich syndrome.","volume":"166","author":"Ariga","year":"2001","journal-title":"J Immunol"},{"issue":"1-3","key":"2019111809041671900_B20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12026-008-8091-4","article-title":"Revertant somatic mosaicism in the wiskott-aldrich syndrome.","volume":"44","author":"Davis","year":"2009","journal-title":"Immunol Res"},{"issue":"11","key":"2019111809041671900_B21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating LV and gammaretroviral vectors.","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol Ther"},{"issue":"12","key":"2019111809041671900_B22","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood.V91.12.4554","article-title":"A 5\u2032 regulatory sequence containing two ets motifs controls the expression of the wiskott-aldrich syndrome protein (wasp) gene in human hematopoietic cells.","volume":"91","author":"Petrella","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2019111809041671900_B23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.17.303","article-title":"Efficacy of gene therapy for wiskott-aldrich syndrome using a was promoter\/cdna-containing LV vector and nonlethal irradiation.","volume":"17","author":"Dupre","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"5","key":"2019111809041671900_B24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ymthe.2004.08.008","article-title":"LV vector-mediated gene transfer in T cells from wiskott-aldrich syndrome patients leads to functional correction.","volume":"10","author":"Dupre","year":"2004","journal-title":"Mol Ther"},{"issue":"12","key":"2019111809041671900_B25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/gt.2008.20","article-title":"Improved LV vectors for wiskott-aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.","volume":"15","author":"Frecha","year":"2008","journal-title":"Gene Ther"},{"issue":"5","key":"2019111809041671900_B26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/mt.2008.43","article-title":"Improvement of migratory defects in a murine model of wiskott-aldrich syndrome gene therapy.","volume":"16","author":"Blundell","year":"2008","journal-title":"Mol Ther"},{"issue":"2","key":"2019111809041671900_B27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased dna methylation in embryonic carcinoma cells.","volume":"69","author":"Challita","year":"1995","journal-title":"J Virol"},{"issue":"10","key":"2019111809041671900_B28","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V94.10.3349.422k05_3349_3357","article-title":"Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector.","volume":"94","author":"Halene","year":"1999","journal-title":"Blood"},{"issue":"5954","key":"2019111809041671900_B29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a LV vector in X-linked adrenoleukodystrophy.","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"issue":"3","key":"2019111809041671900_B30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/hum.2010.060","article-title":"Large-scale manufacture and characterization of a LV vector produced for clinical ex vivo gene therapy application.","volume":"22","author":"Merten","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2019111809041671900_B31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1074-7613(00)80590-7","article-title":"Wiskott-aldrich syndrome protein-deficient mice reveal a role for wasp in T but not B cell activation.","volume":"9","author":"Snapper","year":"1998","journal-title":"Immunity"},{"issue":"5","key":"2019111809041671900_B32","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor gamma chain(null) mice.","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111809041671900_B33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/mt.2010.259","article-title":"Development of b-lineage predominant LV vectors for use in genetic therapies for B cell disorders.","volume":"19","author":"Sather","year":"2011","journal-title":"Mol Ther"},{"issue":"11","key":"2019111809041671900_B34","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2009-09-241869","article-title":"B cell-specific LV gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.","volume":"115","author":"Kerns","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111809041671900_B35","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1073\/pnas.91.7.2567","article-title":"Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.","volume":"91","author":"Challita","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111809041671900_B36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/bbrc.1999.0292","article-title":"The identification and characterization of two promoters and the complete genomic sequence for the wiskott-aldrich syndrome gene.","volume":"256","author":"Hagemann","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2019111809041671900_B37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.gt.3302863","article-title":"LV vectors targeting wasp expression to hematopoietic cells, efficiently transduce and correct cells from was patients.","volume":"14","author":"Charrier","year":"2007","journal-title":"Gene Ther"},{"issue":"4","key":"2019111809041671900_B38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20081773","article-title":"The wiskott-aldrich syndrome protein is required for inkt cell maturation and function.","volume":"206","author":"Locci","year":"2009","journal-title":"J Exp Med"},{"issue":"3","key":"2019111809041671900_B39","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2004-03-1003","article-title":"Wiskott-aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response.","volume":"105","author":"Westerberg","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111809041671900_B40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nri1939","article-title":"Receptor editing in lymphocyte development and central tolerance.","volume":"6","author":"Nemazee","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111809041671900_B41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/blood-2009-08-237560","article-title":"Systemic autoimmunity and defective fas ligand secretion in the absence of the wiskott-aldrich syndrome protein.","volume":"116","author":"Nikolov","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2019111809041671900_B42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth1103","article-title":"High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).","volume":"4","author":"Schmidt","year":"2007","journal-title":"Nat Methods"},{"issue":"7","key":"2019111809041671900_B43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ng.607","article-title":"Variants near dmrt1, tert and atf7ip are associated with testicular germ cell cancer.","volume":"42","author":"Turnbull","year":"2010","journal-title":"Nat Genet"},{"issue":"14","key":"2019111809041671900_B44","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/sj.onc.1203492","article-title":"A murine atfa-associated factor with transcriptional repressing activity.","volume":"19","author":"De Graeve","year":"2000","journal-title":"Oncogene"},{"issue":"5","key":"2019111809041671900_B45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (tlr7)\u2013driven accumulation of a novel cd11c+ B-cell population is important for the development of autoimmunity.","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111809041671900_B46","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2002-11-3489","article-title":"Defects in T-cell-mediated immunity to influenza virus in murine wiskott-aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.","volume":"102","author":"Strom","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111809041671900_B47","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaci.2011.03.030","article-title":"LV-mediated gene therapy leads to improvement of B-cell functionality in a murine model of wiskott-aldrich syndrome.","volume":"127","author":"Bosticardo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"2019111809041671900_B48","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","article-title":"X-linked thrombocytopenia (xlt) due to was mutations: clinical characteristics, long-term outcome, and treatment options.","volume":"115","author":"Albert","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111809041671900_B49","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with wiskott-aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111809041671900_B50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.","volume":"17","author":"Baum","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"7313","key":"2019111809041671900_B51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and hmga2 activation after gene therapy of human [bgr]-thalassaemia.","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4395\/1352404\/zh801912004395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4395\/1352404\/zh801912004395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T13:33:27Z","timestamp":1593869607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/19\/4395\/29985\/Ubiquitous-highlevel-gene-expression-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":51,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-03-340711","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]}}}